BioCardia Faces Delisting Concerns
Ticker: BCDA · Form: 8-K · Filed: Apr 4, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: BCDA
TL;DR
BioCardia might get delisted, major red flag.
AI Summary
BioCardia, Inc. filed an 8-K on April 4, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of April 1, 2025. The company, previously known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This filing indicates potential issues with BioCardia's continued listing on a stock exchange, which could significantly impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- Tiger X Medical, Inc. (company) — Former company name
- April 1, 2025 (date) — Date of earliest event reported
- April 4, 2025 (date) — Filing date
FAQ
What specific listing rule or standard has BioCardia, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that BioCardia, Inc. has failed to satisfy, only that a notice has been issued.
What is the potential consequence of failing to satisfy a continued listing rule?
The consequence of failing to satisfy a continued listing rule is typically delisting from the stock exchange.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 1, 2025.
What was BioCardia, Inc. formerly known as?
BioCardia, Inc. was formerly known as Tiger X Medical, Inc.
Where is BioCardia, Inc. headquartered?
BioCardia, Inc. is headquartered at 320 Soquel Way, Sunnyvale, California 94085.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding BioCardia, Inc. (BCDA).